CVRX insider transaction filings
CVRx, Inc. — 39 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-13. Screen CVRX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-13 | 4 | Binkowski Brent — CHIEF OPERATING OFFICER | Purchase (P): 26,223 @ $2.91 | EDGAR |
| 2026-08-13 | 4 | Binkowski Brent — CHIEF OPERATING OFFICER | Sale (S): 1,309 @ $2.55 | EDGAR |
| 2026-06-03 | 4 | SHADAN MARTHA — Director | Grant/award (A): 8,720 @ $0 · Grant/award (A): 11,182 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Hill, Mitch C. — Director | Grant/award (A): 8,720 @ $0 · Grant/award (A): 11,182 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Jain Mudit K. — Director | Grant/award (A): 8,720 @ $0 · Grant/award (A): 11,182 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Ballinger Kevin J. — Director | Grant/award (A): 8,720 @ $0 · Grant/award (A): 11,182 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Nielsen Kirk G. — Director | Grant/award (A): 8,720 @ $0 · Grant/award (A): 11,182 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | SLATTERY JOSEPH P — Director | Grant/award (A): 8,720 @ $0 · Grant/award (A): 11,182 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | DALE MICHAEL D — Director | Grant/award (A): 29,005 @ $0 · Grant/award (A): 36,252 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Adamson Philip B. — Chief Medical Officer | Grant/award (A): 41,000 @ $0 · Sale (S): 1,262 @ $7.90 · Grant/award (A): 62,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Morrison Gregory — CHIEF HUMAN RESOURCES OFFICER | Grant/award (A): 34,000 @ $0 · Grant/award (A): 154,500 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | John Robert Allen — Chief Revenue Officer | Grant/award (A): 35,000 @ $0 · Sale (S): 3,964 @ $7.90 · Grant/award (A): 52,000 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | VERRASTRO PAUL — CHIEF MKTG & STRAT OFFICER | Grant/award (A): 45,000 @ $0 · Sale (S): 1,284 @ $7.90 · Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | OASHEIM JARED — CHIEF FINANCIAL OFFICER | Grant/award (A): 61,000 @ $0 · Sale (S): 1,744 @ $7.90 · Grant/award (A): 91,000 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Binkowski Brent — CHIEF OPERATING OFFICER | Grant/award (A): 15,000 @ $0 · Grant/award (A): 23,000 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Hykes Kevin — PRES & CEO, Director | Grant/award (A): 159,000 @ $0 · Sale (S): 7,763 @ $7.90 · Grant/award (A): 238,000 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Jain Mudit K. — Director | Purchase (P): 46,800 @ $6.36 | EDGAR |
| 2026-02-18 | 4 | Jain Mudit K. — Director | Purchase (P): 600 @ $4.64 | EDGAR |
| 2026-01-08 | 4/A | JOHNSON & JOHNSON — 10% owner Johnson & Johnson Innovation - JJDC, Inc. — 10% owner | Sale (S): 16,000 @ $10.03 · Sale (S): 6,337 @ $10.03 | EDGAR |
| 2025-12-01 | 4 | JOHNSON & JOHNSON — 10% owner Johnson & Johnson Innovation - JJDC, Inc. — 10% owner | Sale (S): 6,337 @ $10.03 | EDGAR |
| 2025-11-25 | 4 | JOHNSON & JOHNSON — 10% owner Johnson & Johnson Innovation - JJDC, Inc. — 10% owner | Sale (S): 500 @ $10 · Sale (S): 2,200 @ $10.06 | EDGAR |
| 2025-11-14 | 4 | JOHNSON & JOHNSON — 10% owner Johnson & Johnson Innovation - JJDC, Inc. — 10% owner | Sale (S): 1,000 @ $10 | EDGAR |
| 2025-11-10 | 4 | JOHNSON & JOHNSON — 10% owner Johnson & Johnson Innovation - JJDC, Inc. — 10% owner | Sale (S): 52,332 @ $10.21 · Sale (S): 200 @ $10 | EDGAR |
| 2025-08-13 | 4 | Binkowski Brent — CHIEF OPERATING OFFICER | Grant/award (A): 16,600 @ $0 · Grant/award (A): 74,900 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Nielsen Kirk G. — Director | Grant/award (A): 19,554 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Jain Mudit K. — Director | Grant/award (A): 19,554 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | SLATTERY JOSEPH P — Director | Grant/award (A): 19,554 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Hill, Mitch C. — Director | Grant/award (A): 19,554 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Ballinger Kevin J. — Director | Grant/award (A): 19,554 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | SHADAN MARTHA — Director | Grant/award (A): 19,554 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Nielsen Kirk G. — Director | Purchase (P): 10,966 @ $5.45 | EDGAR |
| 2025-05-14 | 4 | Nielsen Kirk G. — Director | Purchase (P): 25,200 @ $4.79 · Purchase (P): 101,413 @ $5.29 · Purchase (P): 61,200 @ $5.23 | EDGAR |
| 2025-05-13 | 4 | Jain Mudit K. — Director | Purchase (P): 1,500 @ $4.66 · Purchase (P): 150 @ $5.26 | EDGAR |
| 2025-05-12 | 4 | Hykes Kevin — PRES & CEO, Director | Purchase (P): 5,000 @ $4.84 | EDGAR |
| 2025-03-04 | 4 | Hykes Kevin — PRES & CEO, Director | Grant/award (A): 98,000 @ $0 · Grant/award (A): 148,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | John Robert Allen — Chief Revenue Officer | Grant/award (A): 55,000 @ $0 · Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | OASHEIM JARED — CHIEF FINANCIAL OFFICER | Grant/award (A): 22,000 @ $0 · Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Adamson Philip B. — Chief Medical Officer | Grant/award (A): 20,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | VERRASTRO PAUL — CHIEF MKTG & STRAT OFFICER | Grant/award (A): 16,000 @ $0 · Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — CVRx, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-11 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-13 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CVRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →